Filing Details
- Accession Number:
- 0000891293-10-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-26 13:00:00
- Reporting Period:
- 2010-05-24
- Filing Date:
- 2010-05-26
- Accepted Time:
- 2010-05-26 19:11:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891293 | Cell Therapeutics Inc | CTIC | Pharmaceutical Preparations (2834) | 911533912 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1201041 | L Richard Love | 501 Elliott Ave West, #400 Seattle WA 98119 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-05-24 | 300 | $0.33 | 1,510,812 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 500 | $0.34 | 1,510,312 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 2,362 | $0.34 | 1,507,950 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 1,100 | $0.34 | 1,506,850 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 7,900 | $0.34 | 1,498,950 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 5,600 | $0.34 | 1,493,350 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 4,400 | $0.34 | 1,488,950 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 5,300 | $0.34 | 1,483,650 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 1,700 | $0.34 | 1,481,950 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 4,300 | $0.35 | 1,477,650 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 2,291 | $0.35 | 1,475,359 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 1,400 | $0.35 | 1,473,959 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 2,100 | $0.35 | 1,471,859 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 2,300 | $0.35 | 1,469,559 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 300 | $0.35 | 1,469,259 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 1,200 | $0.35 | 1,468,059 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 1,300 | $0.36 | 1,466,759 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 800 | $0.36 | 1,465,959 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 2,000 | $0.36 | 1,463,959 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 2,600 | $0.36 | 1,461,359 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 1,700 | $0.36 | 1,459,659 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 2,700 | $0.36 | 1,456,959 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 2,400 | $0.36 | 1,454,559 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 1,800 | $0.36 | 1,452,759 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 1,700 | $0.36 | 1,451,059 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 1,347 | $0.36 | 1,449,712 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 800 | $0.37 | 1,448,912 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 1,300 | $0.37 | 1,447,612 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 100 | $0.37 | 1,447,512 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-24 | 100 | $0.37 | 1,447,412 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
